Key Points
โข First-line therapies for functional dyspepsia, including proton pump inhibitors and Helicobacter pylori eradication, provide limited symptom relief in a substantial proportion of patients.
โข Functional dyspepsia and gastroparesis share overlapping symptoms but differ in predominant pathophysiological mechanisms, requiring tailored therapeutic strategies.
โข Predominantly central neuromodulators are most appropriate for epigastric pain syndrome, whereas predominantly peripheral neuromodulators are better suited for postprandial distress syndrome and gastroparesis-related nausea and vomiting.
โข A pragmatic, symptom-oriented, and mechanism-based approach may facilitate individualized treatment selection and optimize clinical outcomes.
๐๐ฅCentral & peripheral #Neuromodulators in #FD & #Gastroparesis: Symptom-Based #ClinicalReviewโผ๏ธ
๐ฏA pragmatic, symptom-oriented & mechanism-based approach facilitate individualized treatment selection & optimize clinical outcomes
๐ onlinelibrary.wiley.com/doi/10.1111/...
#ANMS #ESNM